KAYTIE FRATZKE: Open Payments
NPI 1497124515 · TULSA, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,547 in 79 payments from 11 companies in 2025. Trend: 2023 $1,004 · 2024 $1,057 · 2025 $1,547
Food & beverage: $1,547
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 9 | $315 |
| Janssen Pharmaceuticals, Inc | 19 | $301 |
| Neurocrine BioSciences, Inc. | 9 | $227 |
| Indivior Inc. | 14 | $214 |
| Alkermes, Inc. | 11 | $164 |
| E.R. Squibb & Sons, L.L.C. | 5 | $109 |
| Otsuka America Pharmaceutical, Inc. | 5 | $91 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $53 |
| Lundbeck LLC | 2 | $30 |
| Axsome Therapeutics, Inc. | 1 | $26 |
Products named: FANAPT, INVEGA SUSTENNA, INGREZZA, SUBLOCADE, COBENFY, ARISTADA, REXULTI, SPRAVATO.
Industry payments across OK — which companies pay providers there.
